Xiang Yu | Regional Immunity | Best Researcher Award

Prof. Xiang Yu | Regional Immunity | Best Researcher Award

Prof. Xiang Yu, Hainan University, China

Prof. Xiang Yu is a distinguished immunologist and professor at Hainan University’s School of Biomedical Engineering. He specializes in regional immunity, with a focus on liver immunity and immune visualization. Holding a PhD from Huazhong University of Science and Technology, he has significantly contributed to tumor immunology and nanomedicine. Prof. Yu has published over 59 SCI-indexed papers, including highly cited works in Nature Communications and ACS Nano. His research innovations, including nanovaccines and biomimetic probes, have garnered international recognition. He has supervised numerous doctoral students and received multiple awards, including the Young Scholar Award from the Chinese Society of Immunology.

Publication Profile

Scopus

Orcid

Education 🎓📖

Prof. Xiang Yu obtained a Bachelor’s degree in Clinical Medicine from Wuhan University of Science and Technology in 2013. He later pursued a PhD in Biomedical Engineering at Huazhong University of Science and Technology, graduating in 2019. His doctoral research focused on immune microenvironment regulation, leading to groundbreaking findings in immune visualization and nanomedicine. During his academic journey, he developed expertise in tumor immunology, bio-nanotechnology, and immunotherapeutics. His education laid the foundation for his pioneering work in targeted liver immunity and innovative vaccine designs.

Experience 🏫🔬

Since 2019, Prof. Xiang Yu has been a professor of immunology at Hainan University, mentoring graduate students and leading cutting-edge research projects. His expertise in immune-targeted therapies has driven advancements in biomedical imaging and tumor vaccines. Over the years, he has published over 59 high-impact journal articles, collaborated on international research projects, and contributed to multiple patents. He also holds editorial roles in prestigious journals, serves as a reviewer for SCI-indexed publications, and has been an invited speaker at global immunology conferences.

Awards and Honors 🏆🎖

Prof. Yu has received four major awards, including the Young Scholar Award from the Chinese Society of Immunology. His groundbreaking research has been recognized with the Annual Best Paper Award by Journal of Nanobiotechnology. He has also earned two ESI Highly Cited Paper awards, highlighting his significant impact in immunology and nanomedicine. His students have won national and municipal prizes in academic competitions under his mentorship.

Research Focus 🔬🧬

Prof. Xiang Yu’s research revolves around regional immunity, particularly liver immunity and immune visualization. His work includes bee venom-based liver endothelial targeting, whole-tumor-cell nanovaccines, and biomimetic probes for inflammatory diseases. His studies have led to novel immune regulation strategies for cancer metastasis and autoimmune disorders. His interdisciplinary approach combines bioengineering, nanotechnology, and immunology to develop innovative diagnostic and therapeutic solutions.

Publication Top Notes

  • Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis (Nature Communications, 2019)

  • Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response (Nature Communications, 2020)

  • Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles (Light: Science & Applications, 2020)

  • Biomimetic nanoplatform with selectively positioned indocyanine green for accurate sentinel lymph node imaging (Nanoscale, 2023)

  • Aptamer-modified melittin micelles efficiently inhibit osteosarcoma deterioration by inducing immunogenic cell death (Colloids and Surfaces B: Biointerfaces, 2025)

  • Breaking CHIPS-Mediated immune evasion with tripterin to promote neutrophil chemotaxis against MRSA infection (International Immunopharmacology, 2024)

  • Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice (International Journal of Molecular Sciences, 2024)

  • Mitochondrial stress response in drug-induced liver injury (Molecular Biology Reports, 2021)

  • Hematoxylin and eosin staining of intact tissues via delipidation and ultrasound (Scientific Reports, 2018)

 

 

Shikun Ge | Engineering antibody | Excellence in Academia Award

Dr. Shikun Ge | Engineering antibody | Excellence in Academia Award

Dr. Shikun Ge, University of Minho, Portugal

Dr. Shikun Ge, born on May 6, 1990, in China, is a distinguished researcher in immunology, biochemistry, and veterinary medicine. Currently pursuing a PhD in Biology at the University of Minho, Dr. Ge has previously earned a Master in Veterinary Medicine from South China Agricultural University and a Bachelor in Veterinary Medicine from Liaocheng University. Her expertise spans immunization, antibody engineering, and veterinary infectious diseases. An accomplished scientist, she has received accolades such as the International Young Scientist Award (2023) and has published extensively on innovative antibody technologies.

Publication Profile

Google Scholar

🎓 Education and Training

Shikun Ge, born on May 6, 1990, in China, is a PhD candidate in Biology at the University of Minho since July 2019. He holds a Master’s in Veterinary Medicine from South China Agricultural University (2018) and a Bachelor’s in Veterinary Medicine from Liaocheng University (2015).

🏅 Honours and Awards

Ge has received the International Young Scientist Award (2023) and was recognized in the Frontrunner 5000 Top Articles in Outstanding S&T Journals of China (2021).

Research Focus

Dr. Shikun Ge’s research primarily focuses on veterinary medicine, immunology, and infectious diseases. Her work encompasses animal disease models, antibody engineering, phage display technology, and immunization. Dr. Ge has made significant contributions in diagnosing and neutralizing canine parvovirus using IgY-scFv, developing anti-SARS-CoV-2 antibodies, and characterizing porcine pestivirus infections. Additionally, her research includes the evaluation of IgY preparation methods and the expression of inflammation-related genes. Her diverse expertise and innovative approaches in antibody generation highlight her impact on veterinary infectious diseases and immunological studies. 📚🔍

 

Publication Top Notes

  • Identification of atypical porcine pestivirus infection in swine herds in China – 58 citations, 2017 🌐
  • Canine Parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein – 25 citations, 2020 🐕
  • Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus – 18 citations, 2022 🦠
  • Expression of inflammation-related genes in the lung of BALB/c mice response to H7N9 influenza A virus with different pathogenicity – 9 citations, 2016 🧪
  • Evaluation of different IgY preparation methods and storage stability as potential animal feed supplement – 8 citations, 2020 🥚
  • Expression profile and tissue-specific distribution of the receptor-interacting protein 3 in BALB/c mice – 7 citations, 2016 🧬
  • Distinct expression profile and histological distribution of NLRP3 inflammasome components in the tissues of Hainan black goat suggest a site-specific role in the inflammatory response – 6 citations, 2017 🐐
  • The domestic hen – 5 citations, 2021 🐓
  • Generation and evaluation of anti-mouse IgG IgY as secondary antibody – 4 citations, 2020 🐭
  • Generation and evaluation of IgY-scFv based mimetics against canine parvovirus – 3 citations, 2021 🦠
  • Immunization of hens – 1 citation, 2021 🐔
  • Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement – 2024 🦢